Number of items: 85.
2024
Heggie, R., Boyd, K. , Kamaruzaman, H. and Wu, O.
(2024)
What methods are currently available for incorporating implementation considerations within the economic evaluation of health technologies? a scoping review.
Health Research Policy and Systems, 22(1),
134.
(doi: 10.1186/s12961-024-01220-9)
(PMID:39350148)
Lai, T.-J., Heggie, R., Kamaruzaman, H.-F., Bouttell, J. and Boyd, K.
(2024)
Economic evaluation of robotic assisted surgery: methods, challenges and opportunities.
Applied Health Economics and Health Policy,
(doi: 10.1007/s40258-024-00920-1)
(PMID:39333303)
(Early Online Publication)
Lai, T.-J., Roxburgh, C. , Boyd, K. A. and Bouttell, J.
(2024)
Clinical effectiveness of robotic versus laparoscopic and open surgery: an overview of systematic reviews.
BMJ Open, 14(9),
e076750.
(doi: 10.1136/bmjopen-2023-076750)
(PMID:39284694)
Gögenur, M. et al.
(2024)
Time from colorectal cancer surgery to adjuvant chemotherapy – post hoc analysis of the SCOT trial.
JAMA Surgery, 159(8),
pp. 865-871.
(doi: 10.1001/jamasurg.2024.1555)
(PMID:38865139)
Skivington, K. et al.
(2024)
Reprint of: 'A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance'.
International Journal of Nursing Studies, 154,
104705.
(doi: 10.1016/j.ijnurstu.2024.104705)
(PMID:38564982)
Minnis, H. et al.
(2024)
Prioritising early childhood to promote the nation’s health, wellbeing and prosperity.
Working Paper.
Academy of Medical Sciences.
Heggie, R., Jaiswal, N. , McCartney, E. , Moss, J., Menne, T., Jones, B., Boyd, K. , Soulis, E., Hawkins, N. and Wu, O.
(2024)
Central venous access devices for the delivery of systemic anticancer therapy: an economic evaluation.
Value in Health, 27(1),
pp. 7-14.
(doi: 10.1016/j.jval.2023.09.2996)
(PMID:37844662)
Murray, S. et al.
(2024)
Randomised placebo-controlled trial of antenatal corticosteroids for planned birth in twins (STOPPIT-3): study protocol.
BMJ Open, 14(1),
e078778.
(doi: 10.1136/bmjopen-2023-078778)
(PMID:38238048)
(PMCID:PMC10806667)
2023
McMeekin, N. et al.
(2023)
Implementation of a national smoke-free prison policy: an economic evaluation within the Tobacco in Prisons (TIPs) study.
Tobacco Control, 32(6),
pp. 701-708.
(doi: 10.1136/tobaccocontrol-2021-056991)
(PMID:35256533)
(PMCID:PMC7615232)
Mcmeekin, N., Sinclair, L., Robinson-Smith, L., Mitchell, A., Bauld, L., Tappin, D. M. and Boyd, K. A.
(2023)
Financial incentives for quitting smoking in pregnancy: are they cost-effective.
Addiction, 118(8),
pp. 1445-1456.
(doi: 10.1111/add.16176)
(PMID:36843417)
Venson, R. , Maheshwari, A., Nelson, S. M. and Boyd, K. A.
(2023)
Setting a tariff for IVF and ICSI treatment: a cost analysis.
Human Fertility,
(doi: 10.1080/14647273.2023.2204409)
(PMID:37300314)
(Early Online Publication)
de Souza Cazarim, M., Cruz-Cazarim, E. L. C., Boyd, K. , Wu, O. and Nunes, A. A.
(2023)
Effect of medication therapy management by pharmaceutical care on blood pressure and cardiovascular risk in hypertension: a systematic review, meta-analysis, and meta-regression.
Pharmaceuticals, 16(6),
845.
(doi: 10.3390/ph16060845)
(PMID:37375792)
(PMCID:PMC10302324)
2022
Tappin, D. et al.
(2022)
Effect of financial voucher incentives provided with UK stop smoking services on the cessation of smoking in pregnant women (CPIT III): pragmatic, multicentre, single blinded, phase 3, randomised controlled trial.
British Medical Journal, 379,
e071522.
(doi: 10.1136/bmj-2022-071522)
(PMID:36261162)
(PMCID:PMC9580214)
Hanna, C.R. , Lemmon, E., Hall, P.S., Ennis, H., Morris, E., McLoone, P. , Boyd, K.A. and Jones, R.J.
(2022)
Cancer trial impact: understanding implementation of the Short Course Oncology Treatment trial findings at a national level.
Clinical Oncology, 34(9),
pp. 554-560.
(doi: 10.1016/j.clon.2022.03.012)
(PMID:35370039)
Kohli-Lynch, C. N., Lewsey, J. , Boyd, K. A. , French, D. D., Jordan, N., Moran, A. E., Sattar, N. , Preiss, D. and Briggs, A. H.
(2022)
Beyond 10-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease.
Circulation, 145(17),
pp. 1312-1323.
(doi: 10.1161/CIRCULATIONAHA.121.057631)
(PMID:35249370)
(PMCID:PMC9022692)
Crawford, K. et al.
(2022)
The Best Services Trial (BeST?): a cluster randomised controlled trial comparing the clinical and cost-effectiveness of New Orleans Intervention Model with Services as Usual (SAU) for infants and young children entering care.
Trials, 23,
122.
(doi: 10.1186/s13063-022-06007-3)
(PMID:35130937)
(PMCID:PMC8819875)
Hunt, K. et al.
(2022)
Process and impact of implementing a smoke-free policy in prisons in Scotland: TIPs mixed-methods study.
Public Health Research, 10(1),
(doi: 10.3310/WGLF1204)
(PMID:35129938)
2021
Tweed, E. J. et al.
(2021)
Evaluation of a national smoke-free prisons policy using medication dispensing: an interrupted time-series analysis.
Lancet Public Health, 6(11),
e795-e804.
(doi: 10.1016/S2468-2667(21)00163-8)
(PMID:34537108)
(PMCID:PMC8554387)
Skivington, K. et al.
(2021)
A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance.
British Medical Journal, 374,
n2061.
(doi: 10.1136/bmj.n2061)
(PMID:34593508)
Hanna, C. R. et al.
(2021)
Three versus six months of adjuvant doublet chemotherapy for patients with colorectal cancer: a multi-country cost-effectiveness and budget impact analysis.
Clinical Colorectal Cancer, 20(3),
pp. 236-244.
(doi: 10.1016/j.clcc.2021.04.001)
(PMID:33992542)
Skivington, K. et al.
(2021)
Framework for the development and evaluation of complex interventions: gap analysis, workshop and consultation-informed update.
Health Technology Assessment, 25(57),
(doi: 10.3310/hta25570)
(PMID:34590577)
Stock, S. J. et al.
(2021)
A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study.
Health Technology Assessment, 25(52),
(doi: 10.3310/hta25520)
(PMID:34498576)
Heggie, R., Boyd, K. and Wu, O.
(2021)
How has implementation been incorporated in health technology assessments in the United Kingdom? A systematic rapid review.
Health Research Policy and Systems, 19,
118.
(doi: 10.1186/s12961-021-00766-2)
Stock, S. J. et al.
(2021)
Development and validation of a risk prediction model of preterm birth for women with preterm labour symptoms (the QUIDS study): a prospective cohort study and individual participant data meta-analysis.
PLoS Medicine, 18(7),
e1003686.
(doi: 10.1371/journal.pmed.1003686)
(PMID:34228732)
Stock, S. J. et al.
(2021)
Cervical ripening at home or in-hospital—prospective cohort study and process evaluation (CHOICE) study: a protocol.
BMJ Open, 11(5),
e050452.
(doi: 10.1136/bmjopen-2021-050452)
(PMID:33947741)
(PMCID:33947741)
Hanna, C. R. , Boyd, K. A. and Jones, R. J.
(2021)
Evaluating cancer research impact: lessons and examples from existing reviews on approaches to research impact assessment.
Health Research Policy and Systems, 19,
36.
(doi: 10.1186/s12961-020-00658-x)
(PMID:33706777)
(PMCID:PMC7953786)
Hanna, C. R. , Boyd, K. A. , Wincenciak, J. , Graham, J., Iveson, T., Jones, R. J. and Wilson, R.
(2021)
Do clinical trials change practice? A longitudinal, international assessment of colorectal cancer prescribing practices.
Cancer Treatment and Research Communications, 28,
100445.
(doi: 10.1016/j.ctarc.2021.100445)
(PMID:34425469)
Turongkaravee, S., Jittikoon, J., Rochanathimoke, O., Boyd, K. , Wu, O. and Chaikledkaew, U.
(2021)
Pharmacogenetic testing for adverse drug reaction prevention: systematic review of economic evaluations and the appraisal of quality matters for clinical practice and implementation.
BMC Health Services Research, 21,
1042.
(doi: 10.1186/s12913-021-07025-8)
(PMID:34600523)
(PMCID:PMC8487501)
2020
Mcmeekin, N., Sinclair, L., Bauld, L., Tappin, D. M. , Mitchell, A. and Boyd, K. A.
(2020)
A protocol for the economic evaluation of the Smoking Cessation in Pregnancy Incentives Trial (CPIT III).
BMJ Open, 10,
e038827.
(doi: 10.1136/bmjopen-2020-038827)
Manca, F., Robinson, E., Dillon, J. F. and Boyd, K. A.
(2020)
Eradicating Hepatitis C: are novel screening strategies for people who inject drugs cost-effective?
International Journal of Drug Policy, 82,
102811.
(doi: 10.1016/j.drugpo.2020.102811)
(PMID:32585583)
Hanna, C. R. , Gatting, L. P., Boyd, K. A. , Robb, K. A. and Jones, R. J.
(2020)
Evidencing the impact of cancer trials: insights from the 2014 UK Research Excellence Framework.
Trials, 21,
486.
(doi: 10.1186/s13063-020-04425-9)
(PMID:32503612)
(PMCID:PMC7275320)
Sinclair, L. et al.
(2020)
The smoking cessation in pregnancy incentives trial (CPIT): study protocol for a phase III randomised controlled trial.
Trials, 21,
183.
(doi: 10.1186/s13063-019-4042-8)
(PMID:32059684)
(PMCID:PMC7023794)
Heggie, R., Boyd, K. , Horne, M., Bruijn, M., Stock, S. and on behalf of the QUIDS research team, .
(2020)
When should we admit for preterm labour? An economic evaluation of the QUIDS prognostic model.
EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].
Heggie, R., Wu, O. , Boyd, K. , Lee, M. M.Y., Petrie, M. C. , McEntegart, M. and Berry, C.
(2020)
Does routine invasive management benefit patients presenting with an acute coronary syndrome and a history of bypass surgery? The use of clinical outcomes compared with cost-effectiveness outcomes.
EUHEA 2020, Oslo, Norway, 7-10 July 2020 [Event cancelled].
2019
Iveson, T. et al.
(2019)
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT.
Health Technology Assessment, 23(64),
(doi: 10.3310/hta23640)
(PMID:31852579)
Hunt, K. et al.
(2019)
Smoke-free prison policy development, implementation, and impact across the entire national prison service in Scotland (TIPs study): a three-phase, mixed methods natural experimental evaluation.
Lancet, 394(S2),
S15.
(doi: 10.1016/S0140-6736(19)32812-0)
Dillon, J. F. et al.
(2019)
Intelligent Liver Function Testing (iLFT): A trial of automated diagnosis and staging of liver disease in Primary Care.
Journal of Hepatology, 71(4),
pp. 699-706.
(doi: 10.1016/j.jhep.2019.05.033)
(PMID:31226388)
Henderson, M. et al.
(2019)
Trial of healthy relationship initiatives for the very early years (THRIVE), evaluating Enhanced Triple P for Baby and Mellow Bumps for those with additional social and care needs during pregnancy and their infants who are at higher risk of maltreatment: study protocol for a randomised controlled trial.
Trials, 20,
499.
(doi: 10.1186/s13063-019-3571-5)
(PMID:31412902)
(PMCID:PMC6694522)
Hatton, M. Q.F. et al.
(2019)
Accelerated, dose escalated, sequential chemoradiotherapy in non-small-cell
lung cancer (ADSCaN): a protocol for a randomised phase II study.
BMJ Open, 9(1),
e019903.
(doi: 10.1136/bmjopen-2017-019903)
(PMID:30700475)
(PMCID:PMC6352760)
Squires, H. and Boyd, K.
(2019)
Use of modelling in the economic evaluation of public health interventions.
In: Edwards, R. T. and McIntosh, E. (eds.)
Applied Health Economics for Public Health Practice and Research.
Series: Handbooks in health economic evaluation.
Oxford University Press.
ISBN 9780198737483
2018
Robles-Zurita, J. A. et al.
(2018)
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.
British Journal of Cancer, 119(11),
pp. 1332-1338.
(doi: 10.1038/s41416-018-0319-z)
(PMID:30420616)
(PMCID:PMC6265336)
Stock, S. J. et al.
(2018)
Quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 1: individual participant data meta-analysis and health economic analysis.
BMJ Open, 8(4),
e020796.
(doi: 10.1136/bmjopen-2017-020796)
(PMID:29627817)
(PMCID:PMC5892771)
Boyd, K. , Dillon, J., Inglis, S. and Rezaeihemami, M.
(2018)
Making Sense of Liver Function Tests: Is the Intelligent Liver Function Test (iLFT) Cost-Effective?
The International Liver Congress 2018, Paris, France, 11-15 Apr 2018.
ISBN 0168-8278
(doi: 10.1016/S0168-8278(18)31885-3)
Iveson, T. J. et al.
(2018)
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Lancet Oncology, 19(4),
pp. 562-578.
(doi: 10.1016/S1470-2045(18)30093-7)
(PMID:29611518)
(PMCID:PMC5883334)
Stock, S. J. et al.
(2018)
Study protocol: quantitative fibronectin to help decision-making in women with symptoms of preterm labour (QUIDS) part 2, UK Prospective Cohort Study.
BMJ Open, 8(4),
e020795.
(doi: 10.1136/bmjopen-2017-020795)
(PMID:29674373)
(PMCID:PMC5914783)
Deidda, M. , Boyd, K. A. , Minnis, H. , Donaldson, J., Brown, K., Boyer, N. R.S. and McIntosh, E.
(2018)
Protocol for the economic evaluation of a complex intervention to improve the mental health of maltreated infants and children in foster care in the UK (The BeST? services trial).
BMJ Open, 8(3),
e020066.
(doi: 10.1136/bmjopen-2017-020066)
(PMID:29540420)
Dillon, J. F. et al.
(2018)
A pilot evaluation of an intelligent liver diagnostic pathway: Making sense of LFTs for
patients, GPs and the NHS in Scotland.
Project Report.
Chief Scientist Office, Edinburgh.
2017
Haghpanahan, H. , Boyd, K.A. , Mackay, D.F. , Mcintosh, E. , Pell, J. and Haw, S.
(2017)
The Effectiveness and Cost-Effectiveness of Tobacco Control Mass Media Campaigns In Scotland.
ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017.
(doi: 10.1016/j.jval.2017.08.007)
Heggie, R., Boyd, K. , Stock, S. and Bruijn, M.
(2017)
How Should We Test For Pre-Term Labour? An Economic Model And Cost-Effectiveness Analysis.
ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017.
A600.
(doi: 10.1016/j.jval.2017.08.1143)
Kohli-Lynch, C.N. , Boyd, K. , Briggs, A. and Delles, C.
(2017)
A Framework for the Cost-Effectiveness Analysis of Novel Biomarker Testing in Cardiovascular Disease.
ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017.
A404-A405.
(doi: 10.1016/j.jval.2017.08.040)
Rezaei Hemami, M., Boyd, K.A. , Inglis, S.K., Dow, E. and Dilon, J.F.
(2017)
Cost Effectivness Of Inteligent Liver Function Test(ILFT) For Investigating Patients With Abnormal Liver Function Test.
ISPOR 20th Annual European Congress, Glasgow, UK, 4-8 Nov 2017.
A597.
(doi: 10.1016/j.jval.2017.08.1129)
Iveson, T. et al.
(2017)
Final DFS Results of the SCOT study: An International Phase III Randomised (1:1) Non-Inferiority Trial Comparing 3 Versus 6 Months of Oxaliplatin Based Adjuvant Chemotherapy for Colorectal Cancer.
42nd ESMO 2017 Congress, Madrid, Spain, 8-12 Sept 2017.
Lawless, C.A. et al.
(2017)
ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC).
UNSPECIFIED
S80-S81.
(doi: 10.1016/S0169-5002(17)30221-0)
2016
Minnis, H. et al.
(2016)
Protocol 15PRT/6090:The Best Services Trial (BeST?): effectiveness and cost-effectiveness of the New Orleans Intervention Model for Infant Mental Health − NCT02653716.
Lancet Protocols,
Boyd, K. , Tappin, D. M. and Bauld, L.
(2016)
Cost-effectiveness of financial incentives for smoking cessation in pregnancy.
Addiction, 111(6),
pp. 115-117.
(doi: 10.1111/add.13374)
(PMID:27157899)
Wu, O. , Boyd, K. , Paul, J. , McCartney, E. , Ritchie, M., Mellon, D., Kelly, L., Dixon-Hughes, J. and Moss, J.
(2016)
Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation.
British Journal of Cancer, 114(9),
pp. 979-985.
(doi: 10.1038/bjc.2016.76)
(PMID:27092784)
Graham, J.S., Boyd, K. , Coxon, F.Y., Wall, L.R., Eatock, M.M., Maughan, T.S., Highley, M., Soulis, E., Conway, F. and Evans, T.
(2016)
A phase II study of capecitabine and oxalplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract.
BMC Research Notes, 9,
161.
(doi: 10.1186/s13104-015-1778-4)
(PMID:26969121)
(PMCID:PMC4788848)
Boyd, K. A. , Briggs, A. H. , Bauld, L., Sinclair, L. and Tappin, D.
(2016)
Are financial incentives cost-effective to support smoking cessation during pregnancy?
Addiction, 111(2),
pp. 360-370.
(doi: 10.1111/add.13160)
(PMID:26370095)
Boyd, K. A. , Balogun, M. O. and Minnis, H.
(2016)
Development of a radical foster care intervention in Glasgow, Scotland.
Health Promotion International, 31(3),
pp. 665-673.
(doi: 10.1093/heapro/dav041)
(PMID:26045403)
2015
Boyd, K. A. , Jones, R. J. , Paul, J. , Birrell, F., Briggs, A. H. and Leung, H. Y.
(2015)
Decision-analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer.
BMJ Open, 5(10),
e007925.
(doi: 10.1136/bmjopen-2015-007925)
(PMID:26482768)
(PMCID:PMC4611206)
Boyd, K. and McIntosh, E.
(2015)
Bronchiolitis of infancy discharge study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluation.
Health Technology Assessment, 19(71),
pp. 1-172.
(doi: 10.3310/hta19710)
(PMID:26364905)
Cunningham, S. et al.
(2015)
Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial.
Lancet, 386(9998),
pp. 1041-1048.
(doi: 10.1016/S0140-6736(15)00163-4)
(PMID:26382998)
(PMCID:PMC4673090)
Tappin, D. et al.
(2015)
Financial incentives for smoking cessation in pregnancy: a randomised controlled trial.
British Medical Journal, 350,
h134.
(doi: 10.1136/bmj.h134)
(PMID:25627664)
2014
Turner-Halliday, F., Watson, N. , Boyer, N. R.S. , Boyd, K. A. and Minnis, H.
(2014)
The feasibility of a randomised controlled trial of Dyadic Developmental Psychotherapy.
BMC Psychiatry, 14,
347.
(doi: 10.1186/s12888-014-0347-z)
(PMID:25551365)
(PMCID:PMC4302079)
Boyer, N. , Boyd, K. A. , Turner-Halliday, F., Watson, N. and Minnis, H.
(2014)
Examining the feasibility of an economic analysis of dyadic developmental psychotherapy for children with maltreatment associated psychiatric problems in the United Kingdom.
BMC Psychiatry, 14,
346.
(doi: 10.1186/s12888-014-0346-0)
(PMID:25492801)
(PMCID:PMC4299309)
Tappin, D. et al.
(2014)
Financial incentives for smoking cessation during pregnancy: a randomised controlled trial.
Lancet, 384,
S4.
(doi: 10.1016/S0140-6736(14)62130-9)
Boyd, K.A. , Briggs, A.H. , Bauld, L., Sinclair, L. and Tappin, D.
(2014)
Are financial incentives cost-effective for smoking cessation amongst pregnant women?
European Journal of Public Health, 24(S2),
p. 146.
(doi: 10.1093/eurpub/cku162.090)
Tappin, D. , Bauld, L., Purves, D., Boyd, K. A. , Sinclair, L., MacAskill, S., McKell, J., Friel, B., McConnachie, A. and Coleman, T.
(2014)
Cessation in Pregnancy Incentives Trial (CPIT): a phase II trial in Scotland 2011-2013.
European Journal of Public Health, 24(S2),
p. 183.
(doi: 10.1093/eurpub/cku163.071)
Boyd, K.A. , Jones, R.J. , Paul, J. , Briggs, A. and Leung, H.Y.
(2014)
A decision-analytic cost-effectiveness model to compare treatment options for radiation recurrent prostate cancer against androgen deprivation therapy.
British Journal of Surgery, 101(s4),
p. 59.
(doi: 10.1002/bjs.9510)
2013
Pritchett, R. et al.
(2013)
A feasibility randomised controlled trial of the New Orleans intervention of infant mental health: a study protocol.
Scientific World Journal, 2013(838042),
(doi: 10.1155/2013/838042)
Boyd, K. and Briggs, A.
(2013)
Statistical issues with trial data and economic modeling for cost-effectiveness evaluation.
In: Tang, W. and Tu, X. (eds.)
Modern Clinical Trial Analysis.
Series: Applied bioinformatics and biostatistics in cancer research.
Springer-Verlag: New York, NY, USA, pp. 149-166.
ISBN 9781461443216
(doi: 10.1007/978-1-4614-4322-3_6)
2012
Ferguson, J., Docherty, G., Bauld, L., Lewis, S., Lorgelly, P., Boyd, K.A. , McEwen, A. and Coleman, T.
(2012)
Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trial.
British Medical Journal, 344,
e1696.
(doi: 10.1136/bmj.e1696)
Roberts, N.J., Boyd, K. , Briggs, A.H. , Caress, A.L. and Partridge, M.R.
(2012)
Nurse led versus lay educators support for those with asthma in primary care: a costing study.
BMC Pulmonary Medicine, 12(52),
(doi: 10.1186/1471-2466-12-52)
Tappin, D.M. et al.
(2012)
The cessation in pregnancy incentives trial (CPIT): study protocol for a randomized controlled trial.
Trials, 13(113),
(doi: 10.1186/1745-6215-13-113)
(PMID:22818493)
(PMCID:PMC3482147)
Watterson, A., Little, D., Young, J.A., Murray, F., Doi, L., Boyd, K.A. and Azim, E.
(2012)
Scoping a public health impact assessment of aquaculture with particular reference to tilapia in the UK.
ISRN Public Health, 2012,
pp. 1-18.
(doi: 10.5402/2012/203796)
2011
Boyd, K.A. , Briggs, A.H. , Fenwick, E., Norrie, J. and Stock, S.
(2011)
Power and sample size for cost-effectiveness analysis: fFN neonatal screening.
Contemporary Clinical Trials, 32(6),
pp. 893-901.
(doi: 10.1016/j.cct.2011.07.007)
Brush, J. et al.
(2011)
The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
Health Technology Assessment, 15(35),
pp. 1-192.
(doi: 10.3310/hta15350)
Bauld, L., Boyd, K. A. , Briggs, A. H. , Chesterman, J., Ferguson, J., Judge, K. and Hiscock, R.
(2011)
One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services.
Nicotine and Tobacco Research, 13(2),
pp. 135-145.
(doi: 10.1093/ntr/ntq222)
Boyd, K.A. , Briggs, A. , Paul, J. , Iveson, T., Midgely, R., Harkin, A., Bates, G., Alexander, L. and Cassidy, J.
(2011)
Analysis of adverse events and quality of life data for an economic evaluation of adjuvant chemotherapy in colorectal cancer: when can we stop collecting?
Trials, 12,
A41.
(doi: 10.1186/1745-6215-12-S1-A41)
2010
Boyd, K.A. , Fenwick, E. and Briggs, A.
(2010)
Using an iterative approach to economic evaluation in the drug development process.
Drug Development Research, 71(8),
pp. 470-477.
(doi: 10.1002/ddr.20421)
Young, J.A., Little, D.C., Watterson, A., Murray, F., Boyd, K. , Leschen, W. and Kodithuwakku, S.
(2010)
Growing green: the emergent role of non-tilapia attributes in marketing tilapia.
Aquaculture: Economics and Management, 14(1),
pp. 63-79.
(doi: 10.1080/13657300903566886)
2009
Boyd, K.A. and Briggs, A.H.
(2009)
Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow.
Addiction, 104(2),
pp. 317-325.
(doi: 10.1111/j.1360-0443.2008.02449.x)
Belton, B., Little, D. and Grady, K.
(2009)
Is responsible aquaculture sustainable aquaculture? WWF and the eco-certification of Tilapia.
Society and Natural Resources, 22(9),
pp. 840-855.
(doi: 10.1080/08941920802506257)
2008
Little, D.C., Murray, F.J., Azim, E., Leschen, W., Boyd, K. , Watterson, A. and Young, J.A.
(2008)
Options for producing a warm-water fish in the UK: limits to 'Green Growth'?
Trends in Food Science and Technology, 19(5),
pp. 255-264.
(doi: 10.1016/j.tifs.2007.12.003)
Watterson, A., Little, D., Young, J.A., Boyd, K., Azim, E. and Murray, F.
(2008)
Towards integration of environmental and health impact assessments for wild capture fishing and farmed fish with particular reference to public health and occupational health dimensions.
International Journal of Enviromental Health Research, 5(4),
pp. 258-277.
(doi: 10.3390/ijerph5040258)
This list was generated on Wed Nov 20 19:58:20 2024 GMT.
https://orcid.org/0000-0002-9764-0113